[Therapeutic significance of the beta-receptor blockade in lithium-induced tremor. Therapeutic trials with Pindolol and Practolol].
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D000328:Adult; D000368:Aged; D000605:Amino Alcohols / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007211:Indoles / Q000627:therapeutic use; D008094:Lithium / Q000009:adverse effects / Q000627:therapeutic use; D008875:Middle Aged; D011217:Practolol / Q000627:therapeutic use; D011618:Psychotic Disorders / Q000188:drug therapy; D014202:Tremor / Q000139:chemically induced / Q000188:drug therapy*
D000319:Adrenergic beta-Antagonists; D000605:Amino Alcohols; D007211:Indoles; D008094:Lithium; D011217:Practolol
Therapeutische Bedeutung der beta-Rezeptorenblockade bei lithiumbedingtem Tremor.